In the last 12 months, insiders at NextCure, Inc. ($NXTC) filed 38 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
NextCure, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Langermann Sol (Chief Scientific Officer) — 3 transactions totaling $0
- Webster Stephen W (Not found) — 2 transactions totaling $0
- Borgman Anne Elizabeth (Not found) — 2 transactions totaling $0
- Guha Udayan (Chief Medical Officer) — 1 transaction totaling $0
- Richman Michael (President & CEO) — 4 transactions totaling $0
View all SEC Filings for NextCure, Inc. (NXTC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Cobourn Steven P. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 14670 | $0.00 | 14,670.0000 | 2,842,448 | 9999.99% | 0.52% |
| Jan. 30, 2026 | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 38190 | $0.00 | 38,190.0000 | 2,842,448 | 9999.99% | 1.34% |
| Jan. 30, 2026 | Mayer Timothy | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 14670 | $0.00 | 14,670.0000 | 2,842,448 | 9999.99% | 0.52% |
| Jan. 30, 2026 | Guha Udayan | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 14670 | $0.00 | 14,670.0000 | 2,842,448 | 9999.99% | 0.52% |
| Jan. 30, 2026 | Kundu Sourav | Sr VP, Dev. & Mfg. | A | Employee Stock Option (Right to Buy) | 8270 | $0.00 | 8,270.0000 | 2,842,448 | 9999.99% | 0.29% |
| Jan. 30, 2026 | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 8270 | $0.00 | 8,270.0000 | 2,842,448 | 9999.99% | 0.29% |
| June 20, 2025 | Houston John G | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 28,006,684 | 9999.99% | 0.07% |
| June 20, 2025 | Jones Elaine V | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 28,006,684 | 9999.99% | 0.07% |
| June 20, 2025 | KABAKOFF DAVID S | Not found | A | Stock Option (Right to Buy) | 28050 | $0.00 | 28,050.0000 | 28,006,684 | 9999.99% | 0.10% |
| June 20, 2025 | Borgman Anne Elizabeth | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 28,006,684 | 9999.99% | 0.07% |
| June 20, 2025 | Webster Stephen W | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 28,006,684 | 9999.99% | 0.07% |
| June 20, 2025 | Feigal Ellen | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 28,006,684 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 2,330,386 | 9999.99% | 2.84% |
| Jan. 31, 2025 | Mayer Timothy | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 2,330,386 | 9999.99% | 5.04% |
| Jan. 31, 2025 | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 2,330,386 | 9999.99% | 5.04% |
| Jan. 31, 2025 | Kundu Sourav | Sr VP, Dev. & Mfg. | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 2,330,386 | 9999.99% | 2.84% |
| Jan. 31, 2025 | Cobourn Steven P. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 2,330,386 | 9999.99% | 5.04% |
| Jan. 31, 2025 | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 305500 | $0.00 | 305,500.0000 | 2,330,386 | 9999.99% | 13.11% |
| June 20, 2024 | Webster Stephen W | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 27,903,040 | 9999.99% | 0.07% |
| June 20, 2024 | KABAKOFF DAVID S | Not found | A | Stock Option (Right to Buy) | 28050 | $0.00 | 28,050.0000 | 27,903,040 | 9999.99% | 0.10% |
| June 20, 2024 | Jones Elaine V | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 27,903,040 | 9999.99% | 0.07% |
| June 20, 2024 | Houston John G | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 27,903,040 | 9999.99% | 0.07% |
| June 20, 2024 | Feigal Ellen | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 27,903,040 | 9999.99% | 0.07% |
| June 20, 2024 | Borgman Anne Elizabeth | Not found | A | Stock Option (Right to Buy) | 18700 | $0.00 | 18,700.0000 | 27,903,040 | 9999.99% | 0.07% |
| March 29, 2024 | Cobourn Steven P. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| March 29, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | A | Employee Stock Option (Right to Buy) | 52900 | $0.00 | 52,900.0000 | 27,836,584 | 9999.99% | 0.19% |
| March 29, 2024 | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| March 29, 2024 | Mayer Timothy | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| March 29, 2024 | Myint Han | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| March 29, 2024 | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 244400 | $0.00 | 244,400.0000 | 27,836,584 | 9999.99% | 0.88% |
| March 29, 2024 | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| Jan. 31, 2024 | Cobourn Steven P. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 27,836,584 | 9999.99% | 0.42% |
| Jan. 31, 2024 | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 27,836,584 | 9999.99% | 0.24% |
| Jan. 31, 2024 | Richman Michael | President & CEO | A | Employee Stock Option (Right to Buy) | 305500 | $0.00 | 305,500.0000 | 27,836,584 | 9999.99% | 1.10% |
| Jan. 31, 2024 | Myint Han | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 27,836,584 | 9999.99% | 0.42% |
| Jan. 31, 2024 | Mayer Timothy | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 27,836,584 | 9999.99% | 0.42% |
| Jan. 31, 2024 | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 27,836,584 | 9999.99% | 0.42% |
| Jan. 31, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 27,836,584 | 9999.99% | 0.24% |